Eloxx finalizes Phase 2 ADPKD trial design, names new CMO

Go back to Eloxx finalizes Phase 2 ADPKD trial design, names new CMO
(NASDAQ: ELOX) Delayed: 13.56 +0.26 (1.95%)
Previous Close $13.30    52 Week High $ 
Open $13.21    52 Week Low $ 
Day High $13.56    P/E N/A 
Day Low $12.84    EPS $ 
Volume 1,819